VI
AMRX icon

Versor Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Versor Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-57,700
Closed -$578K – 599
2025
Q3 		$578K Buy
+57,700
New +$518K 0.11% 269
2025
Q2 		– Sell
-14,300
Closed -$120K – 693
2025
Q1 		$120K Buy
+14,300
New +$119K 0.02% 674
2024
Q4 		– Sell
-40,200
Closed -$334K – 740
2024
Q3 		$334K Buy
40,200
+26,400
+191% +$206K 0.05% 559
2024
Q2 		$87.6K Sell
13,800
-57,400
-81% -$364K 0.02% 691
2024
Q1 		$431K Buy
+71,200
New +$401K 0.09% 378
2022
Q3 		– Sell
-133,600
Closed -$425K – 783
2022
Q2 		$425K Buy
+133,600
New +$484K 0.02% 533

Other funds holding AMRX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Versor Investments's AMRX Position: Q4 2025 in Review

Versor Investments sold out of Amneal Pharmaceuticals (AMRX) in Q4 2025, closing a stake of 57,700 shares — an estimated $578K sold.

Versor Investments first reported a position in AMRX in Q2 2022 and held it in 6 quarters. The position peaked at $578K in Q3 2025. 277 funds tracked by Wall St. Rank hold AMRX as of Q4 2025.

  • Versor Investments reported no remaining Amneal Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 57,700 Amneal Pharmaceuticals shares in Q4 2025, an estimated $578K.
  • Versor Investments first reported a position in Amneal Pharmaceuticals in Q2 2022 and held it in 6 quarters.
  • Versor Investments's Amneal Pharmaceuticals position peaked at $578K in Q3 2025.
  • 277 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.